Linagliptin—Role in the Reversal of Aβ‐Mediated Impairment of Insulin Signaling and Reduced Neurotoxicity in AD Pathogenesis: Some Considerations

Publisher: John Wiley & Sons Inc

E-ISSN: 1755-5949|21|12|962-963

ISSN: 1755-5930

Source: CNS: NEUROSCIENCE AND THERAPEUTICS, Vol.21, Iss.12, 2015-12, pp. : 962-963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract